FEATURED/ARCHIVES (03/05/24)
Quetiapine for Major Depressive Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Virtual Care Use in Primary Care or Specialty Care Settings · August 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Canadian Guidelines on Prevention, Assessment and Treatment of Depression among Older Adults · January 2021
Publications (Guidelines)
Canadian Coalition for Seniors’ Mental Health
Vitamin D Supplementation for the Prevention and/or Treatment of Cardiovascular Disease, Cancer, and Other Conditions in Residents of Long-Term Care Facilities · July 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder · July 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Treatment Programs for Substance Use Disorder · June 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Rapid Access Models for Substance Use Services: A Rapid Review · October 2020
Publications (Books-Reports)
Canadian Centre on Substance Use and Addiction
Self-Management Capacity in Adults with Type 2 Diabetes Using Educational Interventions: A Pilot Study (Nurses and Midwives in the Digital Age) (Meetings-Events) · December 2021
Publications (Chapters)
IOS Press
Incentives and Support Programs to Improve Adherence to Tuberculosis Treatment · February 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Capsaicin for Acute or Chronic Non-Cancer Pain: A Review of Guidelines · June 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Bupropion for Treatment Resistant Depression · April 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders · June 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Design for a Virtual Peer-to-Peer Knowledge to Action Platform for Type 2 Diabetes (Challenges of Trustable AI and Added-Value on Health) (Meetings-Events) · May 2022
Publications (Chapters)
IOS Press
Maternal Vitamin D Status among Different Ethnic Groups and Its Potential Contribution to Adverse Pregnancy and Child Outcomes (Vitamin D Deficiency) · January 2020
Publications (Chapters)
IntechOpen Books
Peer Support Programs for Youth Mental Health · November 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Repetitive Transcranial Magnetic Stimulation for People with Treatment-Resistant Depression: A Health Technology Assessment · May 2021
Publications (Books-Reports)
NCBI>Ontario Health Technology Assessment Series
The Use of Robotics in Dementia Care: An Ethical Perspective (Informatics and Technology in Clinical Care and Public Health) (Meetings-Events) · January 2022
Publications (Chapters)
IOS Press
Capsaicin for Acute or Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Safety, and Cost-Effectiveness · July 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Telephone Triage Services · September 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
WHO Systematic Review for Complementary Feeding for ASF (Animal Source Foods) · October 2023
Publications (Books-Reports)
World Health Organization